Your session is about to expire
← Back to Search
PEMF Therapy for Postoperative Pain After Orthopedic Surgery
N/A
Recruiting
Led By Geoffrey D Abrams, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 days
Summary
This trial is testing whether PEMF therapy can help reduce pain in patients who have had shoulder or knee surgery. PEMF therapy uses electromagnetic waves to interact with the body's cells, which may reduce pain and speed up healing. The study will measure pain levels, medication use, and physical function after surgery. PEMF therapy has been evaluated as a therapeutic strategy for pain management in several clinical scenarios, showing positive efficacy and safety profiles.
Who is the study for?
This trial is for adults over 18 who are having shoulder or knee surgery and can do post-op physical therapy. They must not have taken NSAIDs a week before surgery, be willing to sign consent, and not drink excessively. Excluded are those with HIV, hepatitis, severe mental illness, certain connective tissue diseases, diabetes, unknown pain causes, recent corticosteroid use (except asthma/eye meds), medical marijuana users, compensation/litigation seekers for musculoskeletal issues.
What is being tested?
The study tests if PEMF therapy using Endonovo SofPulse reduces pain after orthopedic surgery on the shoulder or knee. It measures how much it lowers pain levels at day 10 post-surgery using a visual scale and checks medication usage and physical function outcomes.
What are the potential side effects?
The information provided does not specify side effects of PEMF therapy; however generally PEMF is considered non-invasive with minimal risks which may include mild discomfort or none at all.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Mean change from baseline in pain scores on the visual analog scale (VAS) at 10 days
Secondary study objectives
Mean change from baseline in narcotic pain medicine use at 10 days
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Active PEMF GroupActive Control1 Intervention
Participants will have a 1 in 2 chance to get the active treatment device post-operatively. The device will be attached to the post-operative dressing. The device is an Endonovo SofPulse that emits a pulsed electromagnetic field (PEMF). Single blind randomization.
Group II: Placebo PEMF GroupPlacebo Group1 Intervention
Participants will have a 1 in 2 chance to get the placebo treatment device post-operatively. The device will be attached to the post-operative dressing. The Endonovo SofPulse placebo device does not emit a pulsed electromagnetic field (PEMF). Single blind randomization.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Pulsed Electromagnetic Field (PEMF) Therapy uses electromagnetic fields to reduce pain and inflammation by promoting cellular repair and improving blood flow, which can accelerate healing in shoulder injuries. Physical therapy, including exercises and manual techniques, helps restore mobility and strength by targeting the muscles and tendons around the shoulder.
Nonsteroidal anti-inflammatory drugs (NSAIDs) reduce inflammation and pain by inhibiting enzymes involved in the inflammatory process. Corticosteroid injections provide potent anti-inflammatory effects, offering relief from severe pain and swelling.
These treatments are crucial for shoulder injury patients as they address pain, inflammation, and functional impairments, facilitating a quicker and more effective recovery.
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,491 Previous Clinical Trials
17,519,177 Total Patients Enrolled
EndonovoUNKNOWN
Geoffrey D Abrams, MDPrincipal InvestigatorStanford University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am willing and able to do physical therapy after surgery.I do not use medical marijuana or CBD oils.I have an autoimmune disease like rheumatoid arthritis or lupus.I have not taken steroids, cancer drugs, or immune system drugs in the last 30 days, except for asthma or eye treatments.I am scheduled for shoulder or knee surgery.I have been diagnosed with fibromyalgia or another chronic pain condition.I have a diagnosed collagen disorder like osteogenesis imperfecta or Ehlers-Danlos syndrome.I have HIV or hepatitis.I am 18 years old or older.I cannot move my shoulder as normal due to injury or paralysis.I have had cancer or a tumor disease in the last 5 years, except for benign skin cancer.I have an active substance abuse problem or a history of it not treated by a doctor for over 5 years.I have shoulder or knee pain, but the cause is unknown.I am taking low-dose aspirin (81 mg).I have diabetes.I am currently experiencing an infection.I drink more than the recommended weekly alcohol limit.I have a neck condition affecting my nerves or spinal cord.I haven't taken any NSAIDs for at least a week before surgery.I have a bone condition like Paget's disease or osteomalacia.
Research Study Groups:
This trial has the following groups:- Group 1: Placebo PEMF Group
- Group 2: Active PEMF Group
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.